Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actemra in Hospitalized Cancer Patients with COVID-19
NCT04370834Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- May 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in coronavirus disease 2019 (COVID-19), pneumonitis, acute respiratory distress syndrome (ARDS), sponsored by National Cancer Institute. Started May 2020; status: terminated.
02
Drugs
tocilizumab
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonitisacute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04370834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370834.